1. Home
  2. EVTL vs IMUX Comparison

EVTL vs IMUX Comparison

Compare EVTL & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

HOLD

Current Price

$3.73

Market Cap

607.7M

Sector

Industrials

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$1.19

Market Cap

75.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTL
IMUX
Founded
2016
2016
Country
United Kingdom
United States
Employees
N/A
66
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
607.7M
75.2M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
EVTL
IMUX
Price
$3.73
$1.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$13.20
$4.25
AVG Volume (30 Days)
714.1K
3.2M
Earning Date
01-01-0001
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.76
$0.51
52 Week High
$7.60
$1.51

Technical Indicators

Market Signals
Indicator
EVTL
IMUX
Relative Strength Index (RSI) 32.65 58.29
Support Level $3.71 $0.64
Resistance Level $4.70 N/A
Average True Range (ATR) 0.22 0.12
MACD 0.00 0.02
Stochastic Oscillator 2.96 51.49

Price Performance

Historical Comparison
EVTL
IMUX

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: